Brian Goff
Förmögenhet: 7 M $ per 2026-09-30
Förmögenhet: 7 M $ per 2026-09-30
Brian M.
Goff is currently Chief Executive Officer & Director at Agios Pharmaceuticals, Inc. since 2022.
Mr. Goff is also Director at Pathways to College Network and Independent Director at Intellia Therapeutics, Inc. starting in 2024.
Former roles include Director at Idenix Pharmaceuticals LLC in 2012, Chief Operating Officer & Director at Neurovance, Inc., Head-Global Hemophilia Franchise at Baxter Healthcare Corp., Chief Commercial, Global Operations Officer & EVP at Alexion Pharmaceuticals, Inc. from 2017 to 2021, Executive Vice President & President-Hematology at Baxalta, Inc. from 2015 to 2016, and VP, Head-Primary Care & Established medicines at Novartis Pharmaceuticals Corp.
Education includes undergraduate studies at Skidmore College and an MBA from The Wharton School of the University of Pennsylvania.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-18 | 184 508 ( 0,31 % ) | 6 M $ | 2026-09-30 | |
| 2026-06-09 | 32 609 ( 0,02 % ) | 393 265 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Verkställande Direktör | 2022-08-08 |
| INTELLIA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-06-13 |
Pathways to College Network | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Verksamhetschef | 2021-07-21 |
| BAXALTA INC | Företagsledare/Principal | 2016-07-01 |
| IDENIX PHARMACEUTICALS INC | Direktör/Styrelseledamot | 2012-05-15 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Företagsledare/Principal | - |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Verksamhetschef | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and other infectious diseases caused by hepatitis and human immunodeficiency virus | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Skidmore College
Skidmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Pathways to College Network | |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån